Niagen Stock Soars 21.06% on Q2 Earnings Surprise

On August 7, 2025, Niagen's stock surged by 21.06% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Niagen Bioscience reported impressive financial results for the second quarter of 2025. The company's earnings per share (EPS) were $0.04, surpassing forecasts by 100%. Revenue grew by 37% year-over-year, reaching $31.1 million. This strong performance was highlighted by the company's CEO, who noted that Niagen delivered an excellent second quarter with $31.1 million in net sales and $3.6 million in net income.

The company's earnings and revenue surprises for the quarter ended June 2025 were +100.00% and +8.99%, respectively. This robust financial performance has contributed to the positive market sentiment surrounding Niagen Bioscience.